🇸🇬 Tabrecta in Singapore

Tabrecta (CAPMATINIB) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Tabrecta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Tabrecta approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Tabrecta in Singapore?

Novartis Pharm is the originator. The local marketing authorisation holder may differ — check the official source linked above.